Amitiza recalls
Amitiza products have been recalled 3 times, most recently on 29 May 2019. The recalling company is usually Mallinckrodt Pharmaceuticals. The most common reason is packaging defects.
Total recalls3since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 29 May 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why amitiza is recalled
Companies
By year
All amitiza recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Amitiza (lubiprostone) capsules, 24 mcg recalledAmitiza | Mallinckrodt Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Amitiza (lubiprostone) capsules, 8 mcg recalledAmitiza | Mallinckrodt Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS III | Amitiza (lubiprostone) capsules 8 mcg recalledAmitiza | Takeda Development Center Americas | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.